Entity Details

Primary name FGFR3
Entity type gene
Source Source Link

Details

PrimaryID2261
RefseqGeneNG_012632
SymbolFGFR3
Namefibroblast growth factor receptor 3
Chromosome4
Location4p16.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-07-27
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsFGFR3_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000165 MAPK cascade
GO:0001501 skeletal system development
GO:0001958 endochondral ossification
GO:0002062 chondrocyte differentiation
GO:0003416 endochondral bone growth
GO:0004713 protein tyrosine kinase activity
GO:0004714 transmembrane receptor protein tyrosine kinase activity
GO:0005007 fibroblast growth factor-activated receptor activity
GO:0005524 ATP binding
GO:0005576 extracellular region
GO:0005634 nucleus
GO:0005783 endoplasmic reticulum
GO:0005794 Golgi apparatus
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway
GO:0007267 cell-cell signaling
GO:0007275 multicellular organism development
GO:0008284 positive regulation of cell population proliferation
GO:0008543 fibroblast growth factor receptor signaling pathway
GO:0009986 cell surface
GO:0010518 positive regulation of phospholipase activity
GO:0017134 fibroblast growth factor binding
GO:0018108 peptidyl-tyrosine phosphorylation
GO:0030133 transport vesicle
GO:0030282 bone mineralization
GO:0033674 positive regulation of kinase activity
GO:0035988 chondrocyte proliferation
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein
GO:0042802 identical protein binding
GO:0043235 receptor complex
GO:0043410 positive regulation of MAPK cascade
GO:0043552 positive regulation of phosphatidylinositol 3-kinase activity
GO:0046777 protein autophosphorylation
GO:0048640 negative regulation of developmental growth
GO:0051897 positive regulation of protein kinase B signaling
GO:0060349 bone morphogenesis
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070977 bone maturation
GO:1902178 fibroblast growth factor receptor apoptotic signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
187601 OMIMThanatophoric dysplasia 2 (TD2)A neonatal lethal skeletal dysplasia causing severe shortening of the limbs, narrow thorax and short ribs. Patients with thanatophoric dysplasia type 2 have straight femurs and cloverleaf skull. The disease is caused by variants affecting the gene represented in this entry.
146000 OMIMHypochondroplasia (HCH)Autosomal dominant disease and is characterized by disproportionate short stature. It resembles achondroplasia, but with a less severe phenotype. The disease is caused by variants affecting the gene represented in this entry.
149730 OMIMLacrimo-auriculo-dento-digital syndrome (LADDS)An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed. The disease is caused by variants affecting the gene represented in this entry.
612247 OMIMCrouzon syndrome with acanthosis nigricans (CAN)Classic Crouzon disease which is caused by mutations in the FGFR2 gene is characterized by craniosynostosis (premature fusion of the skull sutures), and facial hypoplasia. Crouzon syndrome with acanthosis nigricans (a skin disorder characterized by pigmentation anomalies), CAN, is considered to be an independent disorder from classic Crouzon syndrome. CAN is characterized by additional more severe physical manifestation, such as Chiari malformation, hydrocephalus, and atresia or stenosis of the choanas, and is caused by a specific mutation (Ala-391 to Glu) in the transmembrane domain of FGFR3. It is proposed to have an autosomal dominant mode of inheritance. The disease is caused by variants affecting the gene represented in this entry.
100800 OMIMAchondroplasia (ACH)A frequent form of short-limb dwarfism. It is characterized by a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. ACH is an autosomal dominant disease. The disease is caused by variants affecting the gene represented in this entry.
616482 OMIMAchondroplasia, severe, with developmental delay and acanthosis nigricans (SADDAN)A severe form of achondroplasia associated with developmental delay and acanthosis nigricans. Patients manifest short-limb dwarfism, with a long, narrow trunk, short extremities, particularly in the proximal (rhizomelic) segments, a large head with frontal bossing, hypoplasia of the midface and a trident configuration of the hands. Acanthosis nigricans is a skin condition characterized by brown-pigmented, velvety verrucosities in body folds and creases. The disease is caused by variants affecting the gene represented in this entry.
602849 OMIMMuenke syndrome (MNKS)A condition characterized by premature closure of coronal suture of skull during development (coronal craniosynostosis), which affects the shape of the head and face. It may be uni- or bilateral. When bilateral, it is characterized by a skull with a small antero-posterior diameter (brachycephaly), often with a decrease in the depth of the orbits and hypoplasia of the maxillae. Unilateral closure of the coronal sutures leads to flattening of the orbit on the involved side (plagiocephaly). The intellect is normal. In addition to coronal craniosynostosis some affected individuals show skeletal abnormalities of hands and feet, sensorineural hearing loss, mental retardation and respiratory insufficiency. The disease is caused by variants affecting the gene represented in this entry.
187600 OMIMThanatophoric dysplasia 1 (TD1)A neonatal lethal skeletal dysplasia. Affected individuals manifest severe shortening of the limbs with macrocephaly, narrow thorax, short ribs, and curved femurs. The disease is caused by variants affecting the gene represented in this entry.
162900 OMIMKeratinocytic non-epidermolytic nevus (KNEN)Epidermal nevi of the common, non-organoid and non-epidermolytic type are benign skin lesions and may vary in their extent from a single (usually linear) lesion to widespread and systematized involvement. They may be present at birth or develop early during childhood. The disease is caused by variants affecting the gene represented in this entry.
610474 OMIMCamptodactyly, tall stature, and hearing loss syndrome (CATSHLS)An autosomal dominant syndrome characterized by permanent and irreducible flexion of one or more fingers of the hand and/or feet, tall stature, scoliosis and/or a pectus excavatum, and hearing loss. Affected individuals have developmental delay and/or mental retardation, and several of these have microcephaly. Radiographic findings included tall vertebral bodies with irregular borders and broad femoral metaphyses with long tubular shafts. On audiological exam, each tested member have bilateral sensorineural hearing loss and absent otoacoustic emissions. The hearing loss was congenital or developed in early infancy, progressed variably in early childhood, and range from mild to severe. Computed tomography and magnetic resonance imaging reveal that the brain, middle ear, and inner ear are structurally normal. The disease is caused by variants affecting the gene represented in this entry.
182000 OMIMKeratosis, seborrheic (KERSEB)A common benign skin tumor. Seborrheic keratoses usually begin with the appearance of one or more sharply defined, light brown, flat macules. The lesions may be sparse or numerous. As they initially grow, they develop a velvety to finely verrucous surface, followed by an uneven warty surface with multiple plugged follicles and a dull or lackluster appearance. The disease is caused by variants affecting the gene represented in this entry.
254500 OMIMMultiple myeloma (MM)A malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. The gene represented in this entry may be involved in disease pathogenesis. A chromosomal aberration involving FGFR3 is found in multiple myeloma. Translocation t(4;14)(p16.3;q32.3) with the IgH locus.
603956 OMIMCervical cancer (CERCA)A malignant neoplasm of the cervix, typically originating from a dysplastic or premalignant lesion previously present at the active squamocolumnar junction. The transformation from mild dysplastic to invasive carcinoma generally occurs slowly within several years, although the rate of this process varies widely. Carcinoma in situ is particularly known to precede invasive cervical cancer in most cases. Cervical cancer is strongly associated with infection by oncogenic types of human papillomavirus. The gene represented in this entry is involved in disease pathogenesis.
273300 OMIMTesticular germ cell tumor (TGCT)A common malignancy in males representing 95% of all testicular neoplasms. TGCTs have various pathologic subtypes including: unclassified intratubular germ cell neoplasia, seminoma (including cases with syncytiotrophoblastic cells), spermatocytic seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma. The gene represented in this entry may be involved in disease pathogenesis.
109800 OMIMBladder cancer (BLC)A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas that begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences. Disease susceptibility is associated with variants affecting the gene represented in this entry. Somatic mutations can constitutively activate FGFR3.

Interactions

349 interactions

InteractorPartnerSourcesPublicationsLink
FGFR3GPSM3HPRD, IntAct14667819 details
FGFR3FGF1BioGRID, DIP, HPRD, IntAct10574949 14613973 14732692 22244757 22955284 8576175 details
FGFR3FGFR3BioGRID, DIP, HPRD, IntAct10918587 11294897 14732692 23972473 24120763 details
FGFR3CEP126BioGRID, HPRD, IntAct16169070 details
FGFR3RPL8BioGRID, HPRD, IntAct16169070 details
FGFR3SLC25A6BioGRID, HPRD, IntAct16169070 details
FGFR3ATF3BioGRID, HPRD, IntAct16169070 details
FGFR3ARAP1BioGRID, HPRD, IntAct16169070 details
FGFR3CHGBBioGRID, HPRD, IntAct16169070 details
FGFR3CTSKBioGRID, HPRD, IntAct16169070 details
FGFR3GTF3C1BioGRID, HPRD, IntAct16169070 details
FGFR3KRT8BioGRID, HPRD, IntAct16169070 details
FGFR3POLA2BioGRID, HPRD, IntAct16169070 details
FGFR3SMG7BioGRID, HPRD, IntAct16169070 details
FGFR3BORABioGRID, HPRD, IntAct16169070 details
FGFR3CCDC17BioGRID, IntAct16169070 details
FGFR3HBZBioGRID, HPRD, IntAct16169070 details
FGFR3HNRNPLBioGRID, HPRD, IntAct16169070 details
FGFR3NDUFS6BioGRID, HPRD, IntAct16169070 details
FGFR3RNF130BioGRID, HPRD, IntAct16169070 details
FGFR3CCN2MINT23142580 details
FGFR3PKMIntAct24606918 32814053 details
FGFR3FGFR2BioGRID, DIP, IntAct23972473 28514442 details
FGFR3FGF8BioGRID, DIP, HPRD10574949 22244757 details
FGFR3FGF2HPRD, IntAct10574949 14613973 details
FGFR3FGF9BioGRID, HPRD, IntAct10574949 14613973 8576175 details
FGFR3HBEGFIntAct32814053 details
FGFR3DPYSIntAct32814053 details
FGFR3DLX3IntAct32814053 details
FGFR3CREMIntAct32814053 details
FGFR3COMTIntAct32814053 details
FGFR3COL2A1IntAct32814053 details
FGFR3CDKN1AIntAct32814053 details
FGFR3TEN1IntAct32814053 details
FGFR3CDK2IntAct32814053 details
FGFR3CAPN3IntAct32814053 details
FGFR3BCAT1IntAct32814053 details
FGFR3TRIM23IntAct32814053 details
FGFR3AIF1IntAct32814053 details
FGFR3HSD3B1IntAct32814053 details
FGFR3HOXC11IntAct32814053 details
FGFR3HOXB7IntAct32814053 details
FGFR3FOXA3IntAct32814053 details
FGFR3GTF2A1IntAct32814053 details
FGFR3GATA3IntAct32814053 details
FGFR3GATA2IntAct32814053 details
FGFR3GATA1IntAct32814053 details
FGFR3GABPB1IntAct32814053 details
FGFR3FOSL2IntAct32814053 details
FGFR3EZH2IntAct32814053 details
FGFR3DVL2IntAct32814053 details
FGFR3ENSAIntAct32814053 details
FGFR3NCF1IntAct32814053 details
FGFR3MICOS10-NBL1IntAct32814053 details
FGFR3NBL1IntAct32814053 details
FGFR3PPP1R12BIntAct32814053 details
FGFR3MYCIntAct32814053 details
FGFR3MPP1IntAct32814053 details
FGFR3MCM7IntAct32814053 details
FGFR3MAOBIntAct32814053 details
FGFR3LASP1IntAct32814053 details
FGFR3KRT33BIntAct32814053 details
FGFR3KRT19IntAct32814053 details
FGFR3KIFC3IntAct32814053 details
FGFR3JUNBIntAct32814053 details
FGFR3JUNIntAct32814053 details
FGFR3IGFBP4IntAct32814053 details
FGFR3ID1IntAct32814053 details
FGFR3HSPD1IntAct32814053 details
FGFR3RBM4IntAct32814053 details
FGFR3PTMAIntAct32814053 details
FGFR3PSME1IntAct32814053 details
FGFR3PSMC6IntAct32814053 details
FGFR3MAPK11IntAct32814053 details
FGFR3PRKAB2IntAct32814053 details
FGFR3PPARAIntAct32814053 details
FGFR3POLR2EIntAct32814053 details
FGFR3PER1IntAct32814053 details
FGFR3PDE6HIntAct32814053 details
FGFR3PRKNIntAct32814053 details
FGFR3ODF2IntAct32814053 details
FGFR3NPAS2IntAct32814053 details
FGFR3NFE2IntAct32814053 details
FGFR3RELAIntAct32814053 details
FGFR3RPS15AIntAct32814053 details
FGFR3RHEBIntAct32814053 details
FGFR3SLC6A13IntAct32814053 details
FGFR3SHOX2IntAct32814053 details
FGFR3RPL31IntAct32814053 details
FGFR3RGRIntAct32814053 details
FGFR3RPS4XIntAct32814053 details
FGFR3TBCCIntAct32814053 details
FGFR3SMARCB1IntAct32814053 details
FGFR3TERF1IntAct32814053 details
FGFR3TSNAXIntAct32814053 details
FGFR3C22orf39IntAct32814053 details
FGFR3UBE2AIntAct32814053 details
FGFR3PEDS1-UBE2V1IntAct32814053 details
FGFR3UBE2V1IntAct32814053 details
FGFR3USF1IntAct32814053 details
FGFR3WNT7AIntAct32814053 details
FGFR3WT1IntAct32814053 details
FGFR3ZBTB14IntAct32814053 details
FGFR3STIM1IntAct32814053 details
FGFR3STACIntAct32814053 details
FGFR3SP2IntAct32814053 details
FGFR3PPP1R11IntAct32814053 details
FGFR3STAMIntAct32814053 details
FGFR3CDK2AP1IntAct32814053 details
FGFR3DPF1IntAct32814053 details
FGFR3UBL4AIntAct32814053 details
FGFR3CBX4IntAct32814053 details
FGFR3BLZF1IntAct32814053 details
FGFR3TCAPIntAct32814053 details
FGFR3CDCA7LIntAct32814053 details
FGFR3CDS2IntAct32814053 details
FGFR3DNAJA3IntAct32814053 details
FGFR3SOCS6IntAct32814053 details
FGFR3CYTIPIntAct32814053 details
FGFR3PDE4DIPIntAct32814053 details
FGFR3CEP57IntAct32814053 details
FGFR3FCHSD2IntAct32814053 details
FGFR3NR1D2IntAct32814053 details
FGFR3TSPAN2IntAct32814053 details
FGFR3TOB1IntAct32814053 details
FGFR3AKAP9IntAct32814053 details
FGFR3TIMM17BIntAct32814053 details
FGFR3FOSL1IntAct32814053 details
FGFR3MCRS1IntAct32814053 details
FGFR3STAM2IntAct32814053 details
FGFR3PPIEIntAct32814053 details
FGFR3SLC7A8IntAct32814053 details
FGFR3ITGB3BPIntAct32814053 details
FGFR3PLCL2IntAct32814053 details
FGFR3TRIM35IntAct32814053 details
FGFR3SNW1IntAct32814053 details
FGFR3ELL2IntAct32814053 details
FGFR3BAHD1IntAct32814053 details
FGFR3KHDC4IntAct32814053 details
FGFR3OIP5IntAct32814053 details
FGFR3PNKPIntAct32814053 details
FGFR3DUSP10IntAct32814053 details
FGFR3RASSF1IntAct32814053 details
FGFR3RABL2BIntAct32814053 details
FGFR3SF3B2IntAct32814053 details
FGFR3RALBP1IntAct32814053 details
FGFR3SDCCAG8IntAct32814053 details
FGFR3BATFIntAct32814053 details
FGFR3P3H3IntAct32814053 details
FGFR3FBLN5IntAct32814053 details
FGFR3PFDN6IntAct32814053 details
FGFR3BAIAP2IntAct32814053 details
FGFR3HSD17B12IntAct32814053 details
FGFR3GOLGA7IntAct32814053 details
FGFR3AP3M2IntAct32814053 details
FGFR3SCAPERIntAct32814053 details
FGFR3RANGRFIntAct32814053 details
FGFR3RNF138IntAct32814053 details
FGFR3ARL6IP4IntAct32814053 details
FGFR3KLF3IntAct32814053 details
FGFR3DBNLIntAct32814053 details
FGFR3KLHL20IntAct32814053 details
FGFR3TUBGCP4IntAct32814053 details
FGFR3IL37IntAct32814053 details
FGFR3AGO2IntAct32814053 details
FGFR3BRPF3IntAct32814053 details
FGFR3BEX3IntAct32814053 details
FGFR3KLHL3IntAct32814053 details
FGFR3TMEM186IntAct32814053 details
FGFR3METTL7AIntAct32814053 details
FGFR3FBXO7IntAct32814053 details
FGFR3NGEFIntAct32814053 details
FGFR3ARL2BPIntAct32814053 details
FGFR3MIIPIntAct32814053 details
FGFR3SEMA4GIntAct32814053 details
FGFR3ELAPOR1IntAct32814053 details
FGFR3ATXN7L1IntAct32814053 details
FGFR3SPRYD7IntAct32814053 details
FGFR3PARP11IntAct32814053 details
FGFR3OTUD7BIntAct32814053 details
FGFR3DPYSL5IntAct32814053 details
FGFR3AKIP1IntAct32814053 details
FGFR3MRAPIntAct32814053 details
FGFR3TEX12IntAct32814053 details
FGFR3KIZIntAct32814053 details
FGFR3VPS11IntAct32814053 details
FGFR3RCOR3IntAct32814053 details
FGFR3GPATCH2LIntAct32814053 details
FGFR3LURAP1IntAct32814053 details
FGFR3ASIC4IntAct32814053 details
FGFR3AGGF1IntAct32814053 details
FGFR3PRPF39IntAct32814053 details
FGFR3LAMTOR1IntAct32814053 details
FGFR3NSD3IntAct32814053 details
FGFR3DEF8IntAct32814053 details
FGFR3ARHGEF38IntAct32814053 details
FGFR3ESRP1IntAct32814053 details
FGFR3WBP1LIntAct32814053 details
FGFR3TET2IntAct32814053 details
FGFR3RBFOX1IntAct32814053 details
FGFR3ADAMTSL4IntAct32814053 details
FGFR3BRWD1IntAct32814053 details
FGFR3TM6SF1IntAct32814053 details
FGFR3MYOZ2IntAct32814053 details
FGFR3CIAO2BIntAct32814053 details
FGFR3MBIPIntAct32814053 details
FGFR3ZNF581IntAct32814053 details
FGFR3VPS54IntAct32814053 details
FGFR3ZCCHC17IntAct32814053 details
FGFR3AUNIPIntAct32814053 details
FGFR3LYNX1-SLURP2IntAct32814053 details
FGFR3LYNX1IntAct32814053 details
FGFR3COA7IntAct32814053 details
FGFR3CENPHIntAct32814053 details
FGFR3MEAF6IntAct32814053 details
FGFR3PALS1IntAct32814053 details
FGFR3CHST8IntAct32814053 details
FGFR3HS1BP3IntAct32814053 details
FGFR3LHX5IntAct32814053 details
FGFR3TOR1AIP2IntAct32814053 details
FGFR3MRPS14IntAct32814053 details
FGFR3TMTC1IntAct32814053 details
FGFR3UCK1IntAct32814053 details
FGFR3RNF208IntAct32814053 details
FGFR3SPRY4IntAct32814053 details
FGFR3NETO2IntAct32814053 details
FGFR3MAP1LC3BIntAct32814053 details
FGFR3TSC22D4IntAct32814053 details
FGFR3NDEL1IntAct32814053 details
FGFR3ZNF436IntAct32814053 details
FGFR3C10orf88IntAct32814053 details
FGFR3PLEKHS1IntAct32814053 details
FGFR3MRM1IntAct32814053 details
FGFR3ACBD4IntAct32814053 details
FGFR3KCTD17IntAct32814053 details
FGFR3E2F8IntAct32814053 details
FGFR3ZC2HC1CIntAct32814053 details
FGFR3HSPBAP1IntAct32814053 details
FGFR3HECTD3IntAct32814053 details
FGFR3FAM184AIntAct32814053 details
FGFR3PHF23IntAct32814053 details
FGFR3TMUB2IntAct32814053 details
FGFR3DSCC1IntAct32814053 details
FGFR3TEX35IntAct32814053 details
FGFR3HAUS8IntAct32814053 details
FGFR3FANK1IntAct32814053 details
FGFR3WDR20IntAct32814053 details
FGFR3CHMP7IntAct32814053 details
FGFR3MSANTD3IntAct32814053 details
FGFR3IFT20IntAct32814053 details
FGFR3THAP3IntAct32814053 details
FGFR3CCDC120IntAct32814053 details
FGFR3PPP1R16AIntAct32814053 details
FGFR3FAM83AIntAct32814053 details
FGFR3RAB2BIntAct32814053 details
FGFR3GLYR1IntAct32814053 details
FGFR3ZNF333IntAct32814053 details
FGFR3ABLIM2IntAct32814053 details
FGFR3BRMS1LIntAct32814053 details
FGFR3LOXL4IntAct32814053 details
FGFR3LONRF2IntAct32814053 details
FGFR3ZNF296IntAct32814053 details
FGFR3CXorf38IntAct32814053 details
FGFR3C8orf48IntAct32814053 details
FGFR3IQUBIntAct32814053 details
FGFR3TTC23LIntAct32814053 details
FGFR3DPPA2IntAct32814053 details
FGFR3FAM163AIntAct32814053 details
FGFR3KLC3IntAct32814053 details
FGFR3TRIM69IntAct32814053 details
FGFR3VPS37AIntAct32814053 details
FGFR3FAM168BIntAct32814053 details
FGFR3ICA1LIntAct32814053 details
FGFR3PPP1R21IntAct32814053 details
FGFR3IQGAP3IntAct32814053 details
FGFR3USH1GIntAct32814053 details
FGFR3ISCA2IntAct32814053 details
FGFR3ASCL4IntAct32814053 details
FGFR3THEM4IntAct32814053 details
FGFR3DNTTIP1IntAct32814053 details
FGFR3ODAD3IntAct32814053 details
FGFR3TENT5BIntAct32814053 details
FGFR3HAUS1IntAct32814053 details
FGFR3ATP5IF1IntAct32814053 details
FGFR3RIMKLAIntAct32814053 details
FGFR3ODF3L2IntAct32814053 details
FGFR3HID1IntAct32814053 details
FGFR3CEP170BIntAct32814053 details
FGFR3SPATS1IntAct32814053 details
FGFR3SPATA24IntAct32814053 details
FGFR3SPRED2IntAct32814053 details
FGFR3TMEM61IntAct32814053 details
FGFR3FAM9AIntAct32814053 details
FGFR3RBM46IntAct32814053 details
FGFR3PLEKHG7IntAct32814053 details
FGFR3KRTAP19-7IntAct32814053 details
FGFR3KRTAP19-5IntAct32814053 details
FGFR3KRTAP8-1IntAct32814053 details
FGFR3NSMCE2IntAct32814053 details
FGFR3CCDC141IntAct32814053 details
FGFR3LHX8IntAct32814053 details
FGFR3STX19IntAct32814053 details
FGFR3ZNF829IntAct32814053 details
FGFR3SPATA12IntAct32814053 details
FGFR3CFAP100IntAct32814053 details
FGFR3BEX5IntAct32814053 details
FGFR3CCDC158IntAct32814053 details
FGFR3C6orf47BioGRID, HPRD14667819 details
FGFR3RADILBioGRID, HPRD16169070 details
FGFR3SH2B1BioGRID, HPRD11827956 details
FGFR3SRPK2BioGRID26167880 details
FGFR3NECTIN1BioGRID22955284 details
FGFR3EPHA4BioGRID, HPRD16365308 details
FGFR3ANOS1BioGRID19696444 details
FGFR3RPS6KA3BioGRID18156174 details
FGFR3CSPG4BioGRID23124902 details
FGFR3ERBB2BioGRID30898150 details
FGFR3ATG5BioGRID26491898 details
FGFR3HSP90AB1BioGRID, IntAct21487019 22939624 details
FGFR3CDC37BioGRID, IntAct21487019 25036637 details
FGFR3STAT3HPRD, IntAct10918587 11294897 11350938 11940572 12244095 12576423 12626508 14551213 25065853 8626374 details
FGFR3GRB2BioGRID, HPRD26344197 9045692 details
FGFR3HSP90AA1BioGRID21487019 22939624 details
FGFR3HSPA1BBioGRID21487019 details
FGFR3HSPA8BioGRID21487019 details
FGFR3HSPA4BioGRID21487019 details
FGFR3SOCS1BioGRID16410555 29991678 details
FGFR3SOCS3BioGRID16410555 details
FGFR3KLBBioGRID17623664 details
FGFR3PTK2BHPRD15105428 details
FGFR3FGF6HPRD8663044 details
FGFR3FGF7HPRD8663044 details
FGFR3FGF3HPRD8663044 details
FGFR3FGF4HPRD8663044 details
FGFR3FGF5HPRD8663044 details
FGFR3FGF17HPRD10751172 details
FGFR3FGF23HPRD12032146 details
FGFR3STAT1HPRD10918587 11294897 11839738 12637327 12817007 15322115 7543024 7657660 7690989 details
FGFR3HSPG2matrixdb24509440 details
FGFR3TMEM30BBioGRID, IntAct28514442 details
FGFR3SDC2BioGRID, IntAct28514442 details
FGFR3ARRDC3BioGRID, IntAct28514442 details
FGFR3SNX11BioGRID, IntAct26186194 28514442 details
FGFR3TMEM231BioGRID, IntAct26186194 28514442 details
FGFR3ILKAPBioGRID26344197 details
FGFR3HEXIM1BioGRID29845934 details
FGFR3LARP7BioGRID29845934 details
FGFR3CUL4BBioGRID30945288 details
FGFR3MKRN2BioGRID32460013 details